Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunologic Markers”

143 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 143 results

Not applicableStudy completedNCT00440206
What this trial is testing

Multicenter Trial of Immunologic Markers to Predict Long Term Virologic Outcomes

Who this might be right for
HIV Infections
Ottawa Hospital Research Institute 50
Post-approval studies (Phase 4)Study completedNCT02622867
What this trial is testing

Lactobacillus Plantarum 3547 Effects Over Inflammatory and Immunologic Markers

Who this might be right for
VOLUNTEERS
Instituto de Investigación Hospital Universitario La Paz 84
Not applicableNot Yet RecruitingNCT06929637
What this trial is testing

Amino Acid Infusion in Kidney Transplant Recipients

Who this might be right for
Short-term Graft FunctionMetabolic EffectsNutritional Effect+3 more
University Hospital, Martin 100
Not applicableUnknownNCT06279936
What this trial is testing

Neurobiological Underpinnings of Neuropsychological Consequences in Long COVID

Who this might be right for
Long COVID
Universiteit Antwerpen 130
Testing effectiveness (Phase 2)Looking for participantsNCT06405230
What this trial is testing

Evaluation of Programmed Death Ligand 1 (PDL1) Response to Treatment in Extracellular Vesicles (EVs), Patient-derived Organoid (PDOs)s and Immune-marker Positron Emission Tomography (PET) Scanning in Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 40
Testing effectiveness (Phase 2)Study completedNCT00002390
What this trial is testing

The Safety and Effectiveness of Different Doses of 1592U89 in HIV-Infected Patients

Who this might be right for
HIV Infections
Glaxo Wellcome
Not applicableStudy completedNCT00001393
What this trial is testing

Genetic Markers for Focal Segmental Glomerulosclerosis

Who this might be right for
Focal Segmental GlomerulosclerosisHIV-Associated Focal Segmental Glomerulosclerosis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 616
Not applicableStudy completedNCT03064958
What this trial is testing

The Acute Effect of Spices on Vascular Health

Who this might be right for
Oxidative Stress
Penn State University 13
Not applicableUnknownNCT05777577
What this trial is testing

Immunological Profile and Microbial Markers in Evaluating the Effectiveness of Probiotic Therapy in RA Patients

Who this might be right for
Rheumatoid Arthritis
Nazarbayev University 50
Not applicableStudy completedNCT01340222
What this trial is testing

Monocyte Chemotactic Protein-1 (MCP-1) Expressing Monocytes to Predict Preterm Delivery: PhenoMAP Study

Who this might be right for
Preterm Labour
Centre Hospitalier Universitaire Dijon 210
Early research (Phase 1)UnknownNCT00005120
What this trial is testing

The Safety and Effectiveness of (+)-Calanolide A in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Sarawak MediChem Pharmaceuticals 16
Not applicableLooking for participantsNCT07064330
What this trial is testing

Next-gen Flow Cytometry to Find Immune Profiles, Treatment Response, and Toxicity Markers in Skin Cancer Patients Treated With Cemiplimab.

Who this might be right for
Cutaneous Squamous Cell Carcinoma (CSCC)
Instituto de Investigación Biomédica de Salamanca 30
Not applicableUnknownNCT02954367
What this trial is testing

Meat and Whey Protein Supplementation in Endurance Athletes

Who this might be right for
Dietary Modification
Universidad Europea de Madrid 44
Not applicableStudy completedNCT02433431
What this trial is testing

Mechanisms of Mindfulness and Stress Resilience: A Mobile App Mindfulness Training Study

Who this might be right for
Psychological StressMindfulness
Carnegie Mellon University 153
Not applicableStudy completedNCT02504255
What this trial is testing

Evaluation of Immunological Markers, Inflammatory and Clinical Relapse Psychological Predictive During Crohn's Disease

Who this might be right for
Crohn Disease
Hospices Civils de Lyon 144
Not applicableLooking for participantsNCT06919913
What this trial is testing

The Effect of Peri-Operative Adjunctive Probiotics on Immunological Markers in Cases of Prosthetic Joint Infection of the Hip and Knee

Who this might be right for
Prosthetic-joint Infection
NYU Langone Health 152
Not applicableNot Yet RecruitingNCT07457515
What this trial is testing

Breastmilk and the Link to Overweight/Obesity and Maternal Diet in the Mother-breastmilk-child Triad

Who this might be right for
Body WeightObesity & OverweightHuman Milk/Breastfeeding+11 more
Warsaw University of Life Sciences 165
Not applicableActive Not RecruitingNCT06554691
What this trial is testing

Understanding the Immune System's Role in Tree Nut and Peanut Allergies: Key Biomarkers for Diagnosis and Treatment Monitoring and Treatment Targets

Who this might be right for
Food AllergyFood Allergy in ChildrenFood Allergy Peanut+3 more
Luxembourg Institute of Health 90
Not applicableStudy completedNCT02410603
What this trial is testing

Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer

Who this might be right for
Lung CancerLung NeoplasmsCancer of Lung+8 more
Mayo Clinic 64
Testing effectiveness (Phase 2)Ended earlyNCT03960541
What this trial is testing

Efprezimod Alfa (CD24Fc, MK-7110) Administration to Decrease Low-Density Lipoprotein (LDL) and Inflammation in Human Immunodeficiency Virus (HIV) Patients (CALIBER) (MK-7110-003)

Who this might be right for
HIV InfectionsDyslipidemias
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 8
Load More Results